STOCK TITAN

VYNE Therapeutics (VYNE) CLO has shares withheld to cover RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VYNE Therapeutics Inc.'s Chief Legal Officer and General Counsel, Mutya Harsch, reported a routine tax-related share disposition. On the vesting of restricted stock units, 3,464 shares of common stock were withheld by the company to cover tax withholding obligations at a value of $0.6507 per share. This was not an open-market trade. After this tax-withholding event, Harsch directly holds 118,434 shares of VYNE common stock.

Positive

  • None.

Negative

  • None.
Insider Harsch Mutya
Role CHIEF LEGAL OFFICER AND GC
Type Security Shares Price Value
Tax Withholding Common Stock 3,464 $0.6507 $2K
Holdings After Transaction: Common Stock — 118,434 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares withheld for taxes 3,464 shares Withheld to satisfy tax withholding on RSU vesting
Tax withholding share value $0.6507 per share Value applied to the 3,464 withheld shares
Shares held after transaction 118,434 shares Directly owned by Mutya Harsch following tax withholding
restricted stock units financial
"in connection with the vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding requirements financial
"withheld by the Issuer to satisfy tax withholding requirements"
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did VYNE (VYNE) report for Mutya Harsch?

VYNE reported that Chief Legal Officer Mutya Harsch had 3,464 common shares withheld to satisfy tax obligations on vested restricted stock units. This is a standard tax-withholding disposition, not an open-market purchase or sale of shares.

How many VYNE (VYNE) shares were withheld for taxes in this filing?

The filing shows 3,464 VYNE common shares were withheld to cover tax withholding requirements tied to restricted stock unit vesting. These shares were retained by the issuer rather than sold in the open market by the executive.

What price per share was used for the VYNE (VYNE) tax withholding?

The tax-withholding disposition used a value of $0.6507 per VYNE common share. This figure reflects the price applied for satisfying tax obligations when the restricted stock units vested for the executive.

How many VYNE (VYNE) shares does Mutya Harsch hold after this transaction?

After the tax-withholding event, Chief Legal Officer Mutya Harsch directly holds 118,434 VYNE common shares. This remaining position reflects her continuing equity stake following the automatic withholding of shares for tax purposes.

Was the VYNE (VYNE) insider transaction an open-market sale?

No, the transaction was not an open-market sale. The 3,464 VYNE shares were withheld by the issuer solely to satisfy tax withholding requirements associated with restricted stock unit vesting, a common administrative mechanism for equity compensation.

What does the Form 4 tax-withholding code F mean for VYNE (VYNE)?

Code F on the Form 4 indicates shares were disposed of to pay the exercise price or tax liability. For VYNE, this means 3,464 shares were withheld from Mutya Harsch’s award to cover tax on vested restricted stock units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harsch Mutya

(Last)(First)(Middle)
C/O VYNE THERAPEUTICS INC.
P.O. BOX 125

(Street)
STEWARTSVILLE NEW JERSEY 08886

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VYNE Therapeutics Inc. [ VYNE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF LEGAL OFFICER AND GC
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026F(1)3,464D$0.6507118,434D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
/s/ Mutya Harsch07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)